Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



March 11, 2019

An Angel Swoops In For Seres

Shares of Seres Therapeutics Inc. (MCRB) were up strongly after news of a collaboration deal with AstraZeneca. In the collaboration deal, MCRB will receive $20M as well as financial support for its research activities in microbiome immuno-oncology. Here’s a recap.

Read Article
March 8, 2019

Earnings Miss Hurts AcelRx

AcelRx (ACRX) shares slumped in trading today after disappointing earnings results. The company reported $613K in revenue vs. $1.51M consensus estimate. While this was less than half of what was expected, it was not a huge surprise since the company missed revenue estimates by comparable margins over the previous five earnings releases. However, there was […]

Read Article
March 7, 2019

Get the Inside Track On Biotech With Mike Patton

Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

Read Article
March 7, 2019

You Want To Talk About A Roller Coaster Ride?

Bio-Path Holdings Inc (BPTH) shares were up dramatically today, and then they fell very, very quickly. The stock’s price rose from under $3 per share back in late February to over $70 per share. While the company did release a report claiming there BP1001 treatment demonstrated “meaningful clinical improvement”, this is a far cry from […]

Read Article
March 5, 2019

AcelRx Just Waiting For FDA Approval

AcelRx Pharmaceuticals (ACRX) shares have been up recently as the company awaits an FDA decision on its product Zalviso. Zalviso has already received approval in the European Union, but the FDA previously requested the company to do an additional trial to address certain concerns. AcelRx successfully completed the additional trial and expects the FDA to […]

Read Article
March 4, 2019

Evoke Will Get You Going This Monday!

Evoke Pharma Inc. (EVOK) shares were down dramatically today after the FDA noted concerns about the company’s product Gimoti, which is currently awaiting FDA approval. Although the FDA’s comments are not indicative of its final conclusion, they nevertheless highlight likely areas of contention over granting approval for the drug, and as a result, investors reacted […]

Read Article
March 1, 2019

European Regulators Give A Helping Hand To Lexicon Pharmaceuticals

Lexicon Pharmaceuticals (LXRX) rallied strongly today after the European Medicines Agency’s Committee for Medicinal Product for Human Use gave LXRX’s Zynquista a positive mention. Zynquista is a joint development between Lexicon and Sanofi. Zynquista’s application for approval in the United States and Europe has been accepted and is currently under review. Here’s a recap.

Read Article
February 28, 2019

Let’s Dive Into Biotech With Mike Patton

Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

Read Article
February 28, 2019

Aceto Corporation Treading Water

Aceto Corporation (ACET) shares are down today after rising yesterday. The company filed for chapter 11 bankruptcy on February 20th, causing the stock to plunge over 65%. The bounce appeared to be merely technical in nature, as trading data overwhelming shows net selling over today’s session. The company plans to make some adjustments in order […]

Read Article
February 26, 2019

The Clock Is Ticking On Karyopharm Therapeutics

Karyopharm Therapeutics Inc (KPTI) shares were down today as the company awaits the FDA’s decision on its Selinexor new drug application (“NDA”). The company’s stock dropped sharply on Friday, losing around 50% of its value due to FDA notes being leaked, in which the FDA voiced skepticism as to the benefit of approving the new […]

Read Article